None listed
Conditions
Interventions
Dietary Supplement : Treatment(KE_AGE2, combined Aster glehni extracts 960mg/day) gourp: Take 1 tablet 2 times per day with water for 12 weeks
Control (Placebo): Same way with treatment
Sponsors
Koreaeundan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adult men and women aged from 55 t0 85 years old who complain memory loss 2) Those who can decipher Korean 3) CERAD-K memory score decreased from 1.0SD to less than 2.0SD compare to the same age and education level gruop (CERAD word list memory or word delayed recall or word recognition) 4) A person who agrees to participate in the test and has signed an informed consent form
Exclusion criteria
Exclusion criteria: 1) A person who is admitted to hospital with malignant tumor, severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, etc.), severe heart disease (unstable angina, myocardial infarction, arrhythmia requiring heart failure treatment) or 3 months after discharge 2) A person with disease causing cognitive impairment such as dementia, Parkinson's disease,cerebral infarction etc. 3) A person who has experience of administering drugs (antipsychotic drugs, degenerative disease agents, brain function improvers, tricyclic antidepressants) for dementia or other cognitive dysfunction within 4 weeks 4) A person whose daily dose of vitamin E preparation is 400 IU or more, or whose dosage decreasing is inevitable. 5) A person who have received estrogen replacement therapy (excluding topical application agents) within 2 months of the start of the test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alzheimer’s Disease Assessment Scale-Korean version-Cognitive subscale total score | — |
Secondary
| Measure | Time frame |
|---|---|
| Alzheimer’s Disease Assessment Scale-Korean version-Cognitive subscale memory score | — |
Countries
Korea, Republic of
Contacts
Public ContactJae-eun Jeong
Neonutra
Outcome results
None listed